"Hepat Oncol"[ Journal] - Search Results

Year	Number of Results
2013	14
2014	45
2015	56
2016	28
2017	17
2018	11
2019	4
2020	22
2021	7
2022	6
2023	6
2024	1

1

Treatment journey of patients with hepatocellular carcinoma using real-world data in British Columbia, Canada.

Seung SJ, Saherawala H, Zagorski B, Tong C, Lim H, Kim P, Marquez V, Gill S, Liu D, Davies JM. Seung SJ, et al. Hepat Oncol. 2024 Mar 14;10(4):HEP50. doi: 10.2217/hep-2023-0004. eCollection 2023 Dec. Hepat Oncol. 2024. PMID: 38495452 Free PMC article.

2

The predictive value of liver tests for the presence of liver metastases.

Kimchy AV, Singh H, Parikh E, Rosenberg J, Sanghavi K, Lewis JH. Kimchy AV, et al. Hepat Oncol. 2023 Oct 12;10(3):HEP48. doi: 10.2217/hep-2023-0003. eCollection 2023 Sep. Hepat Oncol. 2023. PMID: 37885607 Free PMC article.

3

Hepatic arterial infusion chemotherapy with or without lenvatinib for unresectable cholangiocarcinoma: a single-center retrospective study.

Wang Y, Wei Z, Zhang Z, Xu J, Wang Y, Chen Q, Zhang Y. Wang Y, et al. Hepat Oncol. 2023 Sep 29;10(2):HEP49. doi: 10.2217/hep-2023-0006. eCollection 2023 Jun. Hepat Oncol. 2023. PMID: 37850031 Free PMC article.

4

Clinical outcomes by Child-Pugh Class in patients with advanced hepatocellular carcinoma in a community oncology setting.

Aly A, Fulcher N, Seal B, Pham T, Wang Y, Paulson S, He AR. Aly A, et al. Hepat Oncol. 2023 Aug 9;10(1):HEP47. doi: 10.2217/hep-2023-0002. eCollection 2023 Mar. Hepat Oncol. 2023. PMID: 37577406 Free PMC article.

5

Management of hepatocellular carcinoma from diagnosis in routine clinical practice.

Lokhandwala T, Aly A, Farrelly E, Willey JP, Lamerato LE, Healey M, Coutinho AD, Seal BS. Lokhandwala T, et al. Hepat Oncol. 2023 Mar 27;9(4):HEP45. doi: 10.2217/hep-2021-0011. eCollection 2022 Dec. Hepat Oncol. 2023. PMID: 37009420 Free PMC article.

6

Uncooled TATO microwave system for liver ablation.

Crespo E, Hermosín A, Villalba Á, Daguer E, Flores J, Periañez J, Martínez-Galdámez M, Santos E. Crespo E, et al. Hepat Oncol. 2023 Mar 6;9(4):HEP46. doi: 10.2217/hep-2022-0002. eCollection 2022 Dec. Hepat Oncol. 2023. PMID: 37009421 Free PMC article.

7

Pathological complete response with immunotherapy and brachytherapy to 15 metastatic liver lesions in a single patient.

Appalanaido GK, Ahmad MZ, Shukor SA, Cheen Hoe AK, Subramaniam MK, Fan AS, Abdul Aziz MZ. Appalanaido GK, et al. Hepat Oncol. 2022 Sep 27;9(3):HEP44. doi: 10.2217/hep-2021-0014. eCollection 2022 Sep. Hepat Oncol. 2022. PMID: 36176484 Free PMC article.

8

Impact of β-blockers on survival outcomes in patients with unresectable hepatocellular carcinoma.

Altshuler E, Aryan M, Kallumkal G, Gao H, Wilson J, Ouni A, De Leo E, Hanayneh W, Pan K. Altshuler E, et al. Hepat Oncol. 2022 May 24;9(2):HEP43. doi: 10.2217/hep-2021-0010. eCollection 2022 Apr. Hepat Oncol. 2022. PMID: 35665305 Free PMC article.

9

Systematic literature review of trials assessing recommended systemic treatments in hepatocellular carcinoma.

Ronnebaum S, Aly A, Patel D, Benavente F, Rueda JD. Ronnebaum S, et al. Hepat Oncol. 2021 Aug 26;9(1):HEP41. doi: 10.2217/hep-2021-0003. eCollection 2022 Mar. Hepat Oncol. 2021. PMID: 34765109 Free PMC article. Review.

10

Transarterial chemoembolization alone or followed by bevacizumab for treatment of colorectal liver metastases.

Fiorentini G, Sarti D, Nardella M, Inchingolo R, Nestola M, Rebonato A, Fiorentini C, Aliberti C, Nani R, Guadagni S. Fiorentini G, et al. Hepat Oncol. 2021 Jul 13;9(1):HEP40. doi: 10.2217/hep-2020-0031. eCollection 2022 Mar. Hepat Oncol. 2021. PMID: 34765108 Free PMC article.

11

Portal vein embolization: rationale, techniques, outcomes and novel strategies.

Chansangrat J, Keeratibharat N. Chansangrat J, et al. Hepat Oncol. 2021 Sep 21;8(4):HEP42. doi: 10.2217/hep-2021-0006. eCollection 2021 Dec. Hepat Oncol. 2021. PMID: 34765107 Free PMC article. Review.

12

Evaluation of tumor mutational burden in small early hepatocellular carcinoma and progressed hepatocellular carcinoma.

Wong M, Kim JT, Cox B, Larson BK, Kim S, Waters KM, Vail E, Guindi M. Wong M, et al. Hepat Oncol. 2021 Aug 3;8(4):HEP39. doi: 10.2217/hep-2020-0034. eCollection 2021 Dec. Hepat Oncol. 2021. PMID: 34765106 Free PMC article.

13

Imaging of chemotherapy-induced liver toxicity: an illustrated overview.

Torri GB, Soldatelli MD, Luersen GF, Almeida Ghezzi CL. Torri GB, et al. Hepat Oncol. 2021 Sep 15;8(4):HEP32. doi: 10.2217/hep-2020-0026. eCollection 2021 Dec. Hepat Oncol. 2021. PMID: 34765105 Free PMC article. Review.

14

Unresectable hepatocellular carcinoma treatment with doxorubicin-eluting polyethylene glycol microspheres: a single-center experience.

Tovar-Felice G, García-Gámez A, Benito-Santamaría V, Balaguer-Paniagua D, Villalba-Auñón J, Sampere-Moragues J. Tovar-Felice G, et al. Hepat Oncol. 2021 Jun 4;8(3):HEP38. doi: 10.2217/hep-2020-0035. eCollection 2021 Sep. Hepat Oncol. 2021. PMID: 34408848 Free PMC article.

15

Locoregional therapy patterns and healthcare economic burden of patients with hepatocellular carcinoma in the USA.

Aly A, Lingohr-Smith M, Lin J, Seal B. Aly A, et al. Hepat Oncol. 2021 Apr 21;8(3):HEP37. doi: 10.2217/hep-2021-0001. eCollection 2021 Sep. Hepat Oncol. 2021. PMID: 34408847 Free PMC article.

16

A rare histologic subtype of hepatocellular carcinoma, sarcomatoid hepatocellular carcinoma: report of a case.

Numbere N, Zhang D, Agostini-Vulaj D. Numbere N, et al. Hepat Oncol. 2020 Dec 29;8(2):HEP33. doi: 10.2217/hep-2020-0027. Hepat Oncol. 2020. PMID: 34084452 Free PMC article.

17

Block PD, Shinn B, Kim JH, Hann HW. Block PD, et al. Hepat Oncol. 2020 Dec 29;8(1):HEP35. doi: 10.2217/hep-2020-0028. Hepat Oncol. 2020. PMID: 33680431 Free PMC article. Review.

18

Characterizing the mechanism behind the progression of NAFLD to hepatocellular carcinoma.

Nahon P, Allaire M, Nault JC, Paradis V. Nahon P, et al. Hepat Oncol. 2020 Dec 29;7(4):HEP36. doi: 10.2217/hep-2020-0017. Hepat Oncol. 2020. PMID: 33680428 Free PMC article. Review.

19

Endotrophin, a pro-peptide of Type VI collagen, is a biomarker of survival in cirrhotic patients with hepatocellular carcinoma.

Leeming DJ, Nielsen SH, Vongsuvanh R, Uchila P, Nielsen MJ, Reese-Petersen AL, van der Poorten D, Eslam M, Schuppan D, Karsdal MA, George J. Leeming DJ, et al. Hepat Oncol. 2020 Dec 18;8(2):HEP32. doi: 10.2217/hep-2020-0030. Hepat Oncol. 2020. PMID: 34084451 Free PMC article.

20

Balloon-occluded chemoembolization for hepatocellular carcinoma: a prospective study of safety, feasibility and outcomes.

Bucalau AM, Tancredi I, Pezzullo M, Leveque R, Picchia S, Laethem JV, Verset G. Bucalau AM, et al. Hepat Oncol. 2020 Oct 13;8(1):HEP31. doi: 10.2217/hep-2020-0022. Hepat Oncol. 2020. PMID: 33680430 Free PMC article.

21

Cirrhotomimetic hepatocellular carcinoma: experience of a single institution and review of the literature.

Xiong MJ, Patel CR, Manne U, Al Diffalha S. Xiong MJ, et al. Hepat Oncol. 2020 Aug 21;8(1):HEP28. doi: 10.2217/hep-2020-0015. Hepat Oncol. 2020. PMID: 33680429 Free PMC article.

22

Towards precision medicine in colorectal cancer liver metastases.

O'Connor JM, Loria FS. O'Connor JM, et al. Hepat Oncol. 2020 Jul 29;7(3):HEP29. doi: 10.2217/hep-2020-0011. Hepat Oncol. 2020. PMID: 32774838 Free PMC article. No abstract available.

23

Erratum.

[No authors listed] [No authors listed] Hepat Oncol. 2020 Jul 24;7(3):HEP30. doi: 10.2217/hep-2020-0999e1. Hepat Oncol. 2020. PMID: 32774839 Free PMC article.

24

Risk assessment criteria in liver transplantation for hepatocellular carcinoma: proposal to improve transplant oncology.

McVey JC, Sasaki K, Firl DJ. McVey JC, et al. Hepat Oncol. 2020 Jul 24;7(3):HEP26. doi: 10.2217/hep-2020-0003. Hepat Oncol. 2020. PMID: 32774836 Free PMC article. Review.

25

Is hepatocellular carcinoma surveillance in high-risk populations effective?

Onyirioha K, Mittal S, G Singal A. Onyirioha K, et al. Hepat Oncol. 2020 Jul 24;7(3):HEP25. doi: 10.2217/hep-2020-0012. Hepat Oncol. 2020. PMID: 32774835 Free PMC article. Review.

26

Epidemiologic, humanistic and economic burden of hepatocellular carcinoma in the USA: a systematic literature review.

Aly A, Ronnebaum S, Patel D, Doleh Y, Benavente F. Aly A, et al. Hepat Oncol. 2020 Jul 21;7(3):HEP27. doi: 10.2217/hep-2020-0024. Hepat Oncol. 2020. PMID: 32774837 Free PMC article. Review.

27

Long-lasting remission in a metastatic hepatocellular carcinoma patient after combined regorafenib therapy and surgery.

Goio E, Ielasi L, Benevento F, Renzulli M, Tovoli F. Goio E, et al. Hepat Oncol. 2020 Jul 3;7(3):HEP24. doi: 10.2217/hep-2020-0014. Hepat Oncol. 2020. PMID: 32774834 Free PMC article.

28

Recent advances of GOLM1 in hepatocellular carcinoma.

Yan J, Zhou B, Li H, Guo L, Ye Q. Yan J, et al. Hepat Oncol. 2020 Jun 29;7(2):HEP22. doi: 10.2217/hep-2020-0006. Hepat Oncol. 2020. PMID: 32647567 Free PMC article. Review.

29

The future of liver transplantation: an interview with Pierre-Alain Clavien.

Clavien PA. Clavien PA. Hepat Oncol. 2020 Jun 22;7(2):HEP23. doi: 10.2217/hep-2020-0021. Hepat Oncol. 2020. PMID: 32647568 Free PMC article.

30

HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance.

Pascut D, Pratama MY, Tiribelli C. Pascut D, et al. Hepat Oncol. 2020 Jun 22;7(2):HEP21. doi: 10.2217/hep-2020-0010. Hepat Oncol. 2020. PMID: 32647566 Free PMC article. No abstract available.

31

Systemic treatment of hepatocellular carcinoma: from sorafenib to combination therapies.

Roderburg C, Özdirik B, Wree A, Demir M, Tacke F. Roderburg C, et al. Hepat Oncol. 2020 May 28;7(2):HEP20. doi: 10.2217/hep-2020-0004. Hepat Oncol. 2020. PMID: 32647565 Free PMC article. Review.

32

Hepatic mesenchymal hamartoma and undifferentiated embryonal sarcoma of the liver: a pathologic review.

Martins-Filho SN, Putra J. Martins-Filho SN, et al. Hepat Oncol. 2020 Apr 7;7(2):HEP19. doi: 10.2217/hep-2020-0002. Hepat Oncol. 2020. PMID: 32647564 Free PMC article. Review.

33

Welcome to Volume 7 of Hepatic Oncology.

Killen C. Killen C. Hepat Oncol. 2020 Apr 2;7(1):HEP14. doi: 10.2217/hep-2020-0005. Hepat Oncol. 2020. PMID: 32273972 Free PMC article. No abstract available.

34

Patient advocacy and the future of systemic therapies in liver cancer: an interview with Ghassan Abou-Alfa.

Abou-Alfa G. Abou-Alfa G. Hepat Oncol. 2020 Mar 31;7(1):HEP15. doi: 10.2217/hep-2020-0008. Hepat Oncol. 2020. PMID: 32273973 Free PMC article.

35

JAK/STAT signaling in hepatocellular carcinoma.

Hin Tang JJ, Hao Thng DK, Lim JJ, Toh TB. Hin Tang JJ, et al. Hepat Oncol. 2020 Mar 18;7(1):HEP18. doi: 10.2217/hep-2020-0001. Hepat Oncol. 2020. PMID: 32273976 Free PMC article. Review.

36

The role of the innate immune system in the development and treatment of hepatocellular carcinoma.

Roderburg C, Wree A, Demir M, Schmelzle M, Tacke F. Roderburg C, et al. Hepat Oncol. 2020 Jan 31;7(1):HEP17. doi: 10.2217/hep-2019-0007. Hepat Oncol. 2020. PMID: 32273975 Free PMC article. Review.

37

Updates of colorectal cancer liver metastases therapy: review on DEBIRI.

Fiorentini G, Sarti D, Nani R, Aliberti C, Fiorentini C, Guadagni S. Fiorentini G, et al. Hepat Oncol. 2020 Jan 21;7(1):HEP16. doi: 10.2217/hep-2019-0010. Hepat Oncol. 2020. PMID: 32273974 Free PMC article. Review.

38

Cytoplasmic translocation of nuclear LSD1 (KDM1A) in human hepatoma cells is induced by its inhibitors.

Yabuta S, Shidoji Y. Yabuta S, et al. Hepat Oncol. 2019 Jun 5;6(2):HEP13. doi: 10.2217/hep-2018-0008. Hepat Oncol. 2019. PMID: 31205679 Free PMC article. Review.

39

Current options and future possibilities for the systemic treatment of hepatocellular carcinoma.

Raoul JL, Frenel JS, Raimbourg J, Gilabert M. Raoul JL, et al. Hepat Oncol. 2019 Jun 4;6(1):HEP11. doi: 10.2217/hep-2019-0001. Hepat Oncol. 2019. PMID: 31244990 Free PMC article. Review.

40

The evolving landscape of precision medicine in primary liver cancer.

Martin SP, Wang XW. Martin SP, et al. Hepat Oncol. 2019 Jun 4;6(2):HEP12. doi: 10.2217/hep-2019-0004. Hepat Oncol. 2019. PMID: 31205678 Free PMC article. Review. No abstract available.

41

Journal Watch: Dr Tu looks back at the most important research articles released in 2018 relating to models and biomarkers of hepatocellular carcinoma.

Tu T. Tu T. Hepat Oncol. 2019 Feb 12;6(1):IJE10. doi: 10.2217/hep-2019-0002. eCollection 2019 Mar. Hepat Oncol. 2019. PMID: 31205677 Free PMC article. No abstract available.

42

Corrigendum.

[No authors listed] [No authors listed] Hepat Oncol. 2018 Dec 21;7(4):1. doi: 10.2217/hep-2017-0017c1. Hepat Oncol. 2018. PMID: 33854763 Free PMC article.

43

Selective internal radiation therapy: an effective treatment for hormonal syndromes in pancreatic neuroendocrine tumors.

Zubiri L, Bilbao JI, Rodríguez J, Sangro B. Zubiri L, et al. Hepat Oncol. 2018 Sep 28;5(2):HEP09. doi: 10.2217/hep-2017-0025. eCollection 2018 Apr. Hepat Oncol. 2018. PMID: 31293777 Free PMC article.

44

Hepatocellular carcinoma treatment: hurdles, advances and prospects.

Kumari R, Sahu MK, Tripathy A, Uthansingh K, Behera M. Kumari R, et al. Hepat Oncol. 2018 Sep 28;5(2):HEP08. doi: 10.2217/hep-2018-0002. eCollection 2018 Apr. Hepat Oncol. 2018. PMID: 31293776 Free PMC article. Review.

45

Transcatheter arterial chemoembolization combined with radiofrequency or microwave ablation for hepatocellular carcinoma: a review.

Galanakis N, Kehagias E, Matthaiou N, Samonakis D, Tsetis D. Galanakis N, et al. Hepat Oncol. 2018 Sep 28;5(2):HEP07. doi: 10.2217/hep-2018-0001. eCollection 2018 Apr. Hepat Oncol. 2018. PMID: 31293775 Free PMC article. Review.

46

Molecular heterogeneity in hepatocellular carcinoma.

Zhu S, Hoshida Y. Zhu S, et al. Hepat Oncol. 2018 Sep 11;5(1):HEP10. doi: 10.2217/hep-2018-0005. eCollection 2018 Jan. Hepat Oncol. 2018. PMID: 30302198 Free PMC article. No abstract available.

47

De novo hepatocellular carcinoma occurrence in hepatitis C cirrhotics treated with direct-acting antiviral agents.

Kuftinec G, Loehfelm T, Corwin M, Durbin-Johnson B, Candido M, Hluhanich R, Sarkar S. Kuftinec G, et al. Hepat Oncol. 2018 Jul 25;5(1):HEP06. doi: 10.2217/hep-2018-0003. eCollection 2018 Jan. Hepat Oncol. 2018. PMID: 30302197 Free PMC article.

48

The impact of antiviral therapy on hepatocellular carcinoma epidemiology.

Colombo M, Lleo A. Colombo M, et al. Hepat Oncol. 2018 May 10;5(1):HEP03. doi: 10.2217/hep-2017-0024. eCollection 2018 Jan. Hepat Oncol. 2018. PMID: 30302194 Free PMC article. Review.

49

How Rap and its GEFs control liver physiology and cancer development. C3G alterations in human hepatocarcinoma.

Sequera C, Manzano S, Guerrero C, Porras A. Sequera C, et al. Hepat Oncol. 2018 Apr 16;5(1):HEP05. doi: 10.2217/hep-2017-0026. eCollection 2018 Jan. Hepat Oncol. 2018. PMID: 30302196 Free PMC article. Review.

50

Molecular classification of hepatocellular adenomas: impact on clinical practice.

Védie AL, Sutter O, Ziol M, Nault JC. Védie AL, et al. Hepat Oncol. 2018 Apr 9;5(1):HEP04. doi: 10.2217/hep-2017-0023. eCollection 2018 Jan. Hepat Oncol. 2018. PMID: 30302195 Free PMC article. Review.

51

Development of shellfish allergy after exposure to dual immune checkpoint blockade.

Brown ZJ, Heinrich B, Greten TF. Brown ZJ, et al. Hepat Oncol. 2018 Feb 9;5(1):HEP02. doi: 10.2217/hep-2017-0021. eCollection 2018 Jan. Hepat Oncol. 2018. PMID: 30302193 Free PMC article.

52

Systemic treatments for hepatocellular carcinoma: challenges and future perspectives.

Tovoli F, Negrini G, Benevento F, Faggiano C, Goio E, Granito A. Tovoli F, et al. Hepat Oncol. 2018 Feb 8;5(1):HEP01. doi: 10.2217/hep-2017-0020. eCollection 2018 Jan. Hepat Oncol. 2018. PMID: 30302192 Free PMC article. Review.

53

Radiologic criteria of response to systemic treatments for hepatocellular carcinoma.

Tovoli F, Renzulli M, Granito A, Golfieri R, Bolondi L. Tovoli F, et al. Hepat Oncol. 2017 Oct;4(4):129-137. doi: 10.2217/hep-2017-0018. Epub 2017 Nov 17. Hepat Oncol. 2017. PMID: 30191059 Free PMC article. Review.

54

Biomarker development for hepatocellular carcinoma early detection: current and future perspectives.

Sengupta S, Parikh ND. Sengupta S, et al. Hepat Oncol. 2017 Oct;4(4):111-122. doi: 10.2217/hep-2017-0019. Epub 2017 Nov 17. Hepat Oncol. 2017. PMID: 30191058 Free PMC article. Review.

55

Locoregional therapies in cholangiocarcinoma.

Labib PL, Davidson BR, Sharma RA, Pereira SP. Labib PL, et al. Hepat Oncol. 2017 Oct;4(4):99-109. doi: 10.2217/hep-2017-0014. Epub 2017 Nov 17. Hepat Oncol. 2017. PMID: 29367874 Free PMC article.

56

Cellular senescence associated immune responses in liver cancer.

Greten TF, Eggert T. Greten TF, et al. Hepat Oncol. 2017 Oct;4(4):123-127. doi: 10.2217/hep-2017-0011. Epub 2017 Nov 17. Hepat Oncol. 2017. PMID: 29230285 Free PMC article. Review.

57

Surgical salvage of recurrence after resection of colorectal liver metastases: incidence and outcomes.

Rahbari NN, D'Angelica MI. Rahbari NN, et al. Hepat Oncol. 2017 Aug 3;4(1):25-33. doi: 10.2217/hep-2017-0002. Online ahead of print. Hepat Oncol. 2017. PMID: 28768424 Free PMC article.

58

Nonalcoholic fatty liver disease and hepatocellular carcinoma.

Klein S, Dufour JF. Klein S, et al. Hepat Oncol. 2017 Jul;4(3):83-98. doi: 10.2217/hep-2017-0013. Epub 2017 Oct 30. Hepat Oncol. 2017. PMID: 30191057 Free PMC article. Review.

59

Chemoembolization versus radioembolization for the treatment of unresectable intrahepatic cholangiocarcinoma in a single institution image-based efficacy and comparative toxicity.

Akinwande O, Shah V, Mills A, Noda C, Weiner E, Foltz G, Saad N. Akinwande O, et al. Hepat Oncol. 2017 Jul;4(3):75-81. doi: 10.2217/hep-2017-0005. Epub 2017 Oct 30. Hepat Oncol. 2017. PMID: 30191056 Free PMC article.

60

'Hug sign': a new radiological sign of intraprocedural success after combined treatment for hepatocellular carcinoma.

Iezzi R, Pompili M, Annicchiarico EB, Garcovich M, Siciliano M, Gasbarrini A, Manfredi R. Iezzi R, et al. Hepat Oncol. 2017 Jul;4(3):69-73. doi: 10.2217/hep-2017-0017. Epub 2017 Oct 30. Hepat Oncol. 2017. PMID: 30191055 Free PMC article.

61

Prognostic signatures from hepatocellular carcinoma biopsy.

Marzi L, Villa E. Marzi L, et al. Hepat Oncol. 2017 Jul;4(3):65-68. doi: 10.2217/hep-2017-0016. Epub 2017 Oct 30. Hepat Oncol. 2017. PMID: 30191054 Free PMC article. No abstract available.

62

Hepatic intra-arterial and systemic chemotherapy followed by maintenance therapy for the treatment of cholangiocarcinoma.

Fiorentini G, Mambrini A, Sarti D, Cantore M, Mulazzani L, Mattioli GM, Guadagni S. Fiorentini G, et al. Hepat Oncol. 2017 Apr;4(2):45-53. doi: 10.2217/hep-2017-0001. Epub 2017 Aug 31. Hepat Oncol. 2017. PMID: 30191053 Free PMC article.

63

Circulating endothelial cells and risk of progression in patients with hepatocellular cancer receiving sorafenib.

Giovanis P, Pianezze G, Vincenzi V, Manuppelli C, Boaretto M, Pastorelli D. Giovanis P, et al. Hepat Oncol. 2017 Apr;4(2):39-43. doi: 10.2217/hep-2016-0011. Epub 2017 Sep 8. Hepat Oncol. 2017. PMID: 30191052 Free PMC article. Review.

64

The TGF-β pathway: a pharmacological target in hepatocellular carcinoma?

Fabregat I, Giannelli G; IT-LIVER Consortium. Fabregat I, et al. Hepat Oncol. 2017 Apr;4(2):35-38. doi: 10.2217/hep-2017-0012. Epub 2017 Jul 6. Hepat Oncol. 2017. PMID: 30191051 Free PMC article. No abstract available.

65

The status of transarterial chemoembolization treatment in the era of precision oncology.

Fako V, Wang XW. Fako V, et al. Hepat Oncol. 2017 Apr;4(2):55-63. doi: 10.2217/hep-2017-0009. Epub 2017 Sep 26. Hepat Oncol. 2017. PMID: 28989699 Free PMC article. Review.

66

When to consider liver transplantation in hepatocellular carcinoma patients?

Ma KW, Cheung TT. Ma KW, et al. Hepat Oncol. 2017 Jan;4(1):15-24. doi: 10.2217/hep-2016-0010. Epub 2017 Jul 6. Hepat Oncol. 2017. PMID: 30191050 Free PMC article. Review.

67

Exploring liver physiology, pathology, TGF-β, EMT, stemness and new developments in liver cancer.

Fabregat I. Fabregat I. Hepat Oncol. 2017 Jan;4(1):9-13. doi: 10.2217/hep-2017-0007. Epub 2017 Jul 6. Hepat Oncol. 2017. PMID: 30191049 Free PMC article.

68

Retrotransposons and genetic instability in hepatocellular carcinoma.

Shukla R. Shukla R. Hepat Oncol. 2017 Jan;4(1):5-8. doi: 10.2217/hep-2017-0010. Epub 2017 Jul 18. Hepat Oncol. 2017. PMID: 30191048 Free PMC article. No abstract available.

69

Fibroblast growth factor 19, a double-edged sword.

Jansen PL. Jansen PL. Hepat Oncol. 2017 Jan;4(1):1-4. doi: 10.2217/hep-2017-0008. Epub 2017 Jul 6. Hepat Oncol. 2017. PMID: 30191047 Free PMC article. No abstract available.

70

Dysregulated fatty acid metabolism in hepatocellular carcinoma.

Wang M, Han J, Xing H, Zhang H, Li Z, Liang L, Li C, Dai S, Wu M, Shen F, Yang T. Wang M, et al. Hepat Oncol. 2016 Oct;3(4):241-251. doi: 10.2217/hep-2016-0012. Epub 2017 Jun 30. Hepat Oncol. 2016. PMID: 30191046 Free PMC article. Review.

71

Monitoring outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection.

Rahnemai-Azar AA, Pandey P, Kamel I, Pawlik TM. Rahnemai-Azar AA, et al. Hepat Oncol. 2016 Oct;3(4):223-239. doi: 10.2217/hep-2016-0009. Epub 2017 Jan 20. Hepat Oncol. 2016. PMID: 30191045 Free PMC article. Review.

72

Pathway of care of hepatocellular carcinoma in 2017.

Invernizzi F, Colombo M. Invernizzi F, et al. Hepat Oncol. 2016 Oct;3(4):217-221. doi: 10.2217/hep-2017-0004. Epub 2017 Jun 21. Hepat Oncol. 2016. PMID: 30191044 Free PMC article. No abstract available.

73

The next generation of hepatocellular cancer experts: what do they think?

Khan SA, McClements S, Reccia I, Evans J, Pai M, Sharma R. Khan SA, et al. Hepat Oncol. 2016 Oct;3(4):213-215. doi: 10.2217/hep-2017-0003. Epub 2017 Jun 30. Hepat Oncol. 2016. PMID: 30191043 Free PMC article. No abstract available.

74

Immune checkpoint inhibitors for hepatocellular carcinoma.

Jensen CE, Loaiza-Bonilla A, Bonilla-Reyes PA. Jensen CE, et al. Hepat Oncol. 2016 Aug;3(3):201-211. doi: 10.2217/hep-2016-0004. Epub 2016 Jun 27. Hepat Oncol. 2016. PMID: 30191042 Free PMC article. Review.

75

RFA plus lyso-thermosensitive liposomal doxorubicin: in search of the optimal approach to cure intermediate-size hepatocellular carcinoma.

Lencioni R, Cioni D. Lencioni R, et al. Hepat Oncol. 2016 Aug;3(3):193-200. doi: 10.2217/hep-2016-0005. Epub 2016 Jun 10. Hepat Oncol. 2016. PMID: 30191041 Free PMC article. Review.

76

Insights into the SIRFLOX study.

Gibbs P. Gibbs P. Hepat Oncol. 2016 Aug;3(3):191-192. doi: 10.2217/hep-2016-0006. Epub 2016 May 12. Hepat Oncol. 2016. PMID: 30191040 Free PMC article.

77

Regorafenib and the RESORCE trial: a new second-line option for hepatocellular carcinoma patients.

Bruix J. Bruix J. Hepat Oncol. 2016 Aug;3(3):187-189. doi: 10.2217/hep-2016-0007. Epub 2016 Aug 19. Hepat Oncol. 2016. PMID: 30191039 Free PMC article.

78

Hepatocellular carcinoma and immune therapy, from a clinical perspective; where are we?

Ulahannan SV, Duffy AG. Ulahannan SV, et al. Hepat Oncol. 2016 Aug;3(3):183-185. doi: 10.2217/hep-2016-0008. Epub 2016 Aug 19. Hepat Oncol. 2016. PMID: 30191038 Free PMC article. No abstract available.

79

Erratum.

[No authors listed] [No authors listed] Hepat Oncol. 2016 Apr;3(2):182. doi: 10.2217/hep.16.1. Epub 2016 Feb 24. Hepat Oncol. 2016. PMID: 30191037 Free PMC article.

80

The role of miRNAs in cholangiocarcinoma.

Howell JA, Khan SA. Howell JA, et al. Hepat Oncol. 2016 Apr;3(2):167-180. doi: 10.2217/hep-2015-0003. Epub 2016 Mar 29. Hepat Oncol. 2016. PMID: 30191036 Free PMC article. Review.

81

Controversies of preoperative portal vein embolization.

May BJ, Madoff DC. May BJ, et al. Hepat Oncol. 2016 Apr;3(2):155-166. doi: 10.2217/hep-2015-0004. Epub 2016 Mar 29. Hepat Oncol. 2016. PMID: 30191035 Free PMC article. Review.

82

Functional imaging of hepatocellular carcinoma.

Hoogenboom TC, Thursz M, Aboagye EO, Sharma R. Hoogenboom TC, et al. Hepat Oncol. 2016 Apr;3(2):137-153. doi: 10.2217/hep-2015-0005. Epub 2016 Mar 29. Hepat Oncol. 2016. PMID: 30191034 Free PMC article. Review.

83

Comparative analysis of current guidelines for the treatment of hepatocellular carcinoma.

Tovoli F, Negrini G, Bolondi L. Tovoli F, et al. Hepat Oncol. 2016 Apr;3(2):119-136. doi: 10.2217/hep-2015-0006. Epub 2016 Mar 23. Hepat Oncol. 2016. PMID: 30191033 Free PMC article. Review.

84

Advances in transarterial therapies for hepatocellular carcinoma: is novel technology leading to better outcomes?

de Baere T, Tselikas L, Deschamps F, Boige V, Ducreux M, Hollebecque A. de Baere T, et al. Hepat Oncol. 2016 Apr;3(2):109-118. doi: 10.2217/hep-2015-0001. Epub 2016 Mar 23. Hepat Oncol. 2016. PMID: 30191032 Free PMC article. Review.

85

What are the options for hepatocellular carcinoma patients who progress under sorafenib?

Lau EY, Lee TK. Lau EY, et al. Hepat Oncol. 2016 Apr;3(2):105-108. doi: 10.2217/hep-2016-0003. Epub 2016 Mar 23. Hepat Oncol. 2016. PMID: 30191031 Free PMC article. No abstract available.

86

Identifying patients at risk from nonalcoholic fatty liver-related hepatocellular carcinomas.

Sayiner M, Younossi ZM. Sayiner M, et al. Hepat Oncol. 2016 Apr;3(2):101-103. doi: 10.2217/hep-2016-0002. Epub 2016 Mar 23. Hepat Oncol. 2016. PMID: 30191030 Free PMC article. No abstract available.

87

Neoadjuvant treatment of biliary tract cancer: state-of-the-art and new perspectives.

Imperatori M, D'Onofrio L, Marrucci E, Pantano F, Zoccoli A, Tonini G. Imperatori M, et al. Hepat Oncol. 2016 Jan;3(1):93-99. doi: 10.2217/hep.15.43. Epub 2015 Nov 30. Hepat Oncol. 2016. PMID: 30191029 Free PMC article. Review.

88

Epidemiology and surgical management of intrahepatic cholangiocarcinoma.

Zhang H, Shen F, Han J, Shen YN, Xie GQ, Wu MC, Yang T. Zhang H, et al. Hepat Oncol. 2016 Jan;3(1):83-91. doi: 10.2217/hep.15.34. Epub 2015 Nov 30. Hepat Oncol. 2016. PMID: 30191028 Free PMC article. Review.

89

Progression of systemic chemotherapy with oxaliplatin-containing regimens for advanced hepatocellular carcinoma in China.

Qin S, Gong X. Qin S, et al. Hepat Oncol. 2016 Jan;3(1):71-81. doi: 10.2217/hep.15.42. Epub 2015 Nov 30. Hepat Oncol. 2016. PMID: 30191027 Free PMC article. Review.

90

The clinical role of 'liquid biopsy' in hepatocellular carcinoma.

Howell JA, Sharma R. Howell JA, et al. Hepat Oncol. 2016 Jan;3(1):45-55. doi: 10.2217/hep.15.38. Epub 2015 Nov 30. Hepat Oncol. 2016. PMID: 30191026 Free PMC article. Review.

91

Role of alcohol in the development and progression of hepatocellular carcinoma.

McKillop IH, Schrum LW, Thompson KJ. McKillop IH, et al. Hepat Oncol. 2016 Jan;3(1):29-43. doi: 10.2217/hep.15.40. Epub 2015 Nov 30. Hepat Oncol. 2016. PMID: 30191025 Free PMC article. Review.

92

Liver cancer screening in high-risk populations.

Sherman M. Sherman M. Hepat Oncol. 2016 Jan;3(1):13-18. doi: 10.2217/hep.15.35. Epub 2015 Nov 30. Hepat Oncol. 2016. PMID: 30191024 Free PMC article. Review.

93

The 9th Annual Conference of the International Liver Cancer Association (ILCA) 2015.

Marquardt JU, Galle PR. Marquardt JU, et al. Hepat Oncol. 2016 Jan;3(1):9-12. doi: 10.2217/hep.15.39. Epub 2015 Nov 30. Hepat Oncol. 2016. PMID: 30191023 Free PMC article.

94

Selected summary for the 2015 Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE).

Villanueva A. Villanueva A. Hepat Oncol. 2016 Jan;3(1):5-8. doi: 10.2217/hep.15.37. Epub 2015 Nov 30. Hepat Oncol. 2016. PMID: 30191022 Free PMC article.

95

Hepatocellular carcinoma: asphyxiate and then cook.

Kolly P, Dufour JF. Kolly P, et al. Hepat Oncol. 2016 Jan;3(1):1-3. doi: 10.2217/hep.15.31. Epub 2015 Nov 6. Hepat Oncol. 2016. PMID: 30191021 Free PMC article. No abstract available.

96

Mechanisms of doxorubicin resistance in hepatocellular carcinoma.

Cox J, Weinman S. Cox J, et al. Hepat Oncol. 2016 Jan 1;3(1):57-59. doi: 10.2217/hep.15.41. Hepat Oncol. 2016. PMID: 26998221 Free PMC article.

97

Targeting glucose metabolism in cancer: new class of agents for loco-regional and systemic therapy of liver cancer and beyond?

Savic LJ, Chapiro J, Duwe G, Geschwind JF. Savic LJ, et al. Hepat Oncol. 2016 Jan 1;3(1):19-28. doi: 10.2217/hep.15.36. Hepat Oncol. 2016. PMID: 26989470 Free PMC article.

98

Liver transplantation in the management of perihilar cholangiocarcinoma.

Gulamhusein AF, Sanchez W. Gulamhusein AF, et al. Hepat Oncol. 2015 Oct;2(4):409-421. doi: 10.2217/hep.15.30. Epub 2015 Nov 6. Hepat Oncol. 2015. PMID: 30191020 Free PMC article. Review.

99

Apoptosis in liver carcinogenesis and chemotherapy.

Moreno-Càceres J, Fabregat I. Moreno-Càceres J, et al. Hepat Oncol. 2015 Oct;2(4):381-397. doi: 10.2217/hep.15.27. Epub 2015 Nov 11. Hepat Oncol. 2015. PMID: 30191019 Free PMC article. Review.

100

Next-generation sequencing and personalized genomic medicine in hepatobiliary malignancies.

Loaiza-Bonilla A, Furth EE, Morrissette JJ. Loaiza-Bonilla A, et al. Hepat Oncol. 2015 Oct;2(4):359-370. doi: 10.2217/hep.15.20. Epub 2015 Nov 11. Hepat Oncol. 2015. PMID: 30191018 Free PMC article. Review.

101

New horizons in ablation therapy for hepatocellular carcinoma.

Freedman J, Nilsson H, Jonas E. Freedman J, et al. Hepat Oncol. 2015 Oct;2(4):349-358. doi: 10.2217/hep.15.28. Epub 2015 Nov 6. Hepat Oncol. 2015. PMID: 30191017 Free PMC article. Review.

102

Aggressive systemic mastocytosis of the liver with cholangitis.

Waldburger N, Rupp C, Klinke S, Wieczorek K, Gotthardt D, Kirchner T, Schirmacher P, Straub BK. Waldburger N, et al. Hepat Oncol. 2015 Oct;2(4):343-347. doi: 10.2217/hep.15.33. Epub 2015 Nov 6. Hepat Oncol. 2015. PMID: 30191016 Free PMC article.

103

Role of ablation: should it be used as primary therapy for early-stage hepatocellular carcinoma?

Pompili M, Francica G. Pompili M, et al. Hepat Oncol. 2015 Oct;2(4):339-342. doi: 10.2217/hep.15.21. Epub 2015 Nov 6. Hepat Oncol. 2015. PMID: 30191015 Free PMC article. No abstract available.

104

Radioembolization as an adjunct therapy to the resection of liver tumors.

Iñarrairaegui M, Sangro B. Iñarrairaegui M, et al. Hepat Oncol. 2015 Oct;2(4):335-338. doi: 10.2217/hep.15.23. Epub 2015 Nov 6. Hepat Oncol. 2015. PMID: 30191014 Free PMC article. No abstract available.

105

Hepatic stem cells and cancers: a pathologist's view.

Theise ND. Theise ND. Hepat Oncol. 2015 Oct;2(4):329-334. doi: 10.2217/hep.15.25. Hepat Oncol. 2015. PMID: 30191013 Free PMC article.

106

The impact of intraoperative ultrasonography on the management of disappearing colorectal liver metastases.

Giuliante F, Panettieri E, Ardito F. Giuliante F, et al. Hepat Oncol. 2015 Oct;2(4):325-328. doi: 10.2217/hep.15.29. Epub 2015 Nov 6. Hepat Oncol. 2015. PMID: 30191012 Free PMC article. No abstract available.

107

DNA methylation in hepatocellular carcinoma: what is the use?

Dekervel J, van Pelt J, Verslype C. Dekervel J, et al. Hepat Oncol. 2015 Oct;2(4):321-323. doi: 10.2217/hep.15.22. Epub 2015 Nov 6. Hepat Oncol. 2015. PMID: 30191011 Free PMC article. No abstract available.

108

The search for precision models clinically relevant to human liver cancer.

Xue W, Wang XW. Xue W, et al. Hepat Oncol. 2015 Oct;2(4):315-319. doi: 10.2217/hep.15.24. Epub 2015 Nov 6. Hepat Oncol. 2015. PMID: 30191010 Free PMC article. No abstract available.

109

Intermediate hepatocellular carcinoma: the role of transarterial therapy.

Chegai F, Orlacchio A, Merolla S, Monti S, Mannelli L. Chegai F, et al. Hepat Oncol. 2015 Oct;2(4):399-408. doi: 10.2217/hep.15.32. Hepat Oncol. 2015. PMID: 26998220 Free PMC article.

110

Current issues on genomic heterogeneity in hepatocellular carcinoma and its implication in clinical practice.

Schulze K, Zucman-Rossi J. Schulze K, et al. Hepat Oncol. 2015 Jul;2(3):291-302. doi: 10.2217/hep.15.16. Epub 2015 Jul 27. Hepat Oncol. 2015. PMID: 30191009 Free PMC article. Review.

111

Hepatic arterial infusional chemotherapy in the management of colorectal cancer liver metastases.

Doussot A, Kemeny NE, D'Angelica MI. Doussot A, et al. Hepat Oncol. 2015 Jul;2(3):275-290. doi: 10.2217/hep.15.9. Epub 2015 Jul 27. Hepat Oncol. 2015. PMID: 30191008 Free PMC article. Review.

112

Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress.

Brunt EM, Paradis V, Sempoux C, Theise ND. Brunt EM, et al. Hepat Oncol. 2015 Jul;2(3):255-273. doi: 10.2217/hep.15.8. Epub 2015 Jul 28. Hepat Oncol. 2015. PMID: 30191007 Free PMC article. Review.

113

Surgical treatment of hepatocellular carcinoma: should resection be performed according to Barcelona Clinic Liver Cancer classification?

Fuster J. Fuster J. Hepat Oncol. 2015 Jul;2(3):245-253. doi: 10.2217/hep.15.18. Epub 2015 Jul 30. Hepat Oncol. 2015. PMID: 30191006 Free PMC article. Review.

114

High level of serum protein DKK1 predicts poor prognosis for patients with hepatocellular carcinoma after hepatectomy.

Shen Q, Yang XR, Tan Y, You H, Xu Y, Chu W, Ge T, Zhou J, Qiu SJ, Shi YH, Zhang Z, Gu J, Wang H, Fan J, Qin W. Shen Q, et al. Hepat Oncol. 2015 Jul;2(3):231-244. doi: 10.2217/hep.15.12. Epub 2015 Apr 1. Hepat Oncol. 2015. PMID: 30191005 Free PMC article.

115

Surveillance for hepatocellular carcinoma in chronic hepatitis B virus infection: for whom.

An J, Lee HC. An J, et al. Hepat Oncol. 2015 Jul;2(3):225-229. doi: 10.2217/hep.15.17. Epub 2015 Jul 28. Hepat Oncol. 2015. PMID: 30191004 Free PMC article. No abstract available.

116

The changing etiology of liver cancer.

Khan SA. Khan SA. Hepat Oncol. 2015 Jul;2(3):221-223. doi: 10.2217/hep.15.13. Epub 2015 Jul 27. Hepat Oncol. 2015. PMID: 30191003 Free PMC article. No abstract available.

117

Our panel of experts highlight the most important research articles across the spectrum of topics relevant to the field of hepatic oncology.

Owens J, Francis H. Owens J, et al. Hepat Oncol. 2015 Jul;2(3):217-219. doi: 10.2217/hep.15.15. Epub 2015 Jul 30. Hepat Oncol. 2015. PMID: 30191002 Free PMC article. No abstract available.

118

Isoform-specific activation of Akt involvement in hepatocarcinogenesis.

Imache MR, Pawlotsky JM, Lerat H. Imache MR, et al. Hepat Oncol. 2015 Jul;2(3):213-216. doi: 10.2217/hep.15.19. Epub 2015 Jul 28. Hepat Oncol. 2015. PMID: 30191001 Free PMC article. No abstract available.

119

How endoplasmic reticulum stress contributes to obesity-driven hepatic tumorigenesis.

Nakagawa H. Nakagawa H. Hepat Oncol. 2015 Jul;2(3):209-211. doi: 10.2217/hep.15.11. Epub 2015 Jul 30. Hepat Oncol. 2015. PMID: 30191000 Free PMC article. No abstract available.

120

Systemic chemotherapy with oxaliplatin is a good option for advanced hepatocellular carcinoma.

Qin S, Wu Q. Qin S, et al. Hepat Oncol. 2015 Jul;2(3):203-207. doi: 10.2217/hep.15.14. Epub 2015 Jul 30. Hepat Oncol. 2015. PMID: 30190999 Free PMC article. No abstract available.

121

The emerging role of positron emission tomography in hepatocellular carcinoma.

Dubash SR, Idowu OA, Sharma R. Dubash SR, et al. Hepat Oncol. 2015 Apr;2(2):191-200. doi: 10.2217/hep.15.6. Epub 2015 Apr 27. Hepat Oncol. 2015. PMID: 30190998 Free PMC article. Review.

122

Liver transplantation in treatment of colorectal liver metastases.

Hagness M. Hagness M. Hepat Oncol. 2015 Apr;2(2):181-190. doi: 10.2217/hep.15.3. Epub 2015 Apr 27. Hepat Oncol. 2015. PMID: 30190997 Free PMC article. Review.

123

Hepatocellular adenoma management: advances but still a long way to go.

Blanc JF, Frulio N, Chiche L, Bioulac-Sage P, Balabaud C. Blanc JF, et al. Hepat Oncol. 2015 Apr;2(2):171-180. doi: 10.2217/hep.14.41. Epub 2015 May 15. Hepat Oncol. 2015. PMID: 30190996 Free PMC article. Review.

124

A role for hepatic surgery in patients with liver metastatic breast cancer: review of literature.

Bacalbaşa N, Alexandrescu ST, Popescu I. Bacalbaşa N, et al. Hepat Oncol. 2015 Apr;2(2):159-170. doi: 10.2217/hep.14.40. Epub 2015 May 15. Hepat Oncol. 2015. PMID: 30190995 Free PMC article. Review.

125

Chemoembolization of hepatocellular carcinoma with HepaSphere™.

Malagari K, Pomoni A, Filippiadis D, Kelekis D. Malagari K, et al. Hepat Oncol. 2015 Apr;2(2):147-157. doi: 10.2217/hep.15.2. Epub 2015 May 5. Hepat Oncol. 2015. PMID: 30190994 Free PMC article. Review.

126

Radiotherapy for liver tumors.

Keane FK, Tanguturi SK, Zhu AX, Dawson LA, Hong TS. Keane FK, et al. Hepat Oncol. 2015 Apr;2(2):133-146. doi: 10.2217/hep.15.7. Epub 2015 Apr 20. Hepat Oncol. 2015. PMID: 30190993 Free PMC article. Review.

127

Radioembolization for hepatocellular carcinoma: current role and future directions - the medical oncologist's perspective.

Gibbs P, Tie J, Bester L. Gibbs P, et al. Hepat Oncol. 2015 Apr;2(2):117-132. doi: 10.2217/hep.14.39. Epub 2015 Apr 20. Hepat Oncol. 2015. PMID: 30190992 Free PMC article. Review.

128

Laser ablation: an alternative to radiofrequency ablation for hepatocellular carcinoma in cirrhotic patients?

Maurizio Pacella C, Francica G, Di Costanzo GG. Maurizio Pacella C, et al. Hepat Oncol. 2015 Apr;2(2):111-115. doi: 10.2217/hep.15.1. Epub 2015 Apr 10. Hepat Oncol. 2015. PMID: 30190991 Free PMC article. No abstract available.

129

Screening and treatment of hepatitis B virus to prevent liver cancer in Africa.

Thursz MR. Thursz MR. Hepat Oncol. 2015 Apr;2(2):105-109. doi: 10.2217/hep.15.4. Epub 2015 Apr 20. Hepat Oncol. 2015. PMID: 30190990 Free PMC article. No abstract available.

130

Resection versus ablation for hepatocellular carcinoma: role of initial treatment.

Tateishi R. Tateishi R. Hepat Oncol. 2015 Apr;2(2):101-103. doi: 10.2217/hep.15.5. Epub 2015 Apr 20. Hepat Oncol. 2015. PMID: 30190989 Free PMC article. No abstract available.

131

The efficacy and effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis.

Singal AG. Singal AG. Hepat Oncol. 2015 Apr;2(2):97-99. doi: 10.2217/hep.14.38. Epub 2015 Apr 10. Hepat Oncol. 2015. PMID: 30190988 Free PMC article. No abstract available.

132

Genetic risk markers for hepatocellular carcinoma in patients with alcoholic liver disease.

Nahon P, Sutton A, Ziol M, Zucman-Rossi J, Trinchet JC, Ganne-Carrié N. Nahon P, et al. Hepat Oncol. 2015 Jan;2(1):63-78. doi: 10.2217/hep.14.26. Epub 2015 Jan 12. Hepat Oncol. 2015. PMID: 30190987 Free PMC article. Review.

133

Contrast-enhanced ultrasound in liver cancer.

Leoni S, Serio I, Pecorelli A, Marinelli S, Bolondi L. Leoni S, et al. Hepat Oncol. 2015 Jan;2(1):51-62. doi: 10.2217/hep.14.25. Epub 2015 Jan 12. Hepat Oncol. 2015. PMID: 30190986 Free PMC article. Review.

134

Nonsurgical multidisciplinary approach for recurrent hepatocellular carcinoma after surgical resection.

Kim KM. Kim KM. Hepat Oncol. 2015 Jan;2(1):29-38. doi: 10.2217/hep.14.31. Epub 2015 Jan 12. Hepat Oncol. 2015. PMID: 30190985 Free PMC article. Review.

135

Liver transplantation for advanced hepatocellular carcinoma: how far can we go?

Suh KS, Lee HW. Suh KS, et al. Hepat Oncol. 2015 Jan;2(1):19-28. doi: 10.2217/hep.14.34. Epub 2015 Jan 12. Hepat Oncol. 2015. PMID: 30190984 Free PMC article. Review.

136

Immune play: defending the liver.

O'Sullivan Coyne G, Greten TF. O'Sullivan Coyne G, et al. Hepat Oncol. 2015 Jan;2(1):15-18. doi: 10.2217/hep.14.35. Epub 2015 Jan 12. Hepat Oncol. 2015. PMID: 30190983 Free PMC article. No abstract available.

137

Our experts highlight the most important research articles across the spectrum of topics relevant to the field of hepatic oncology.

Tu T, Shackel N, McCaughan G. Tu T, et al. Hepat Oncol. 2015 Jan;2(1):13-14. doi: 10.2217/hep.14.33. Epub 2015 Jan 12. Hepat Oncol. 2015. PMID: 30190982 Free PMC article. No abstract available.

138

Implementation of systems theory in liver cancer research.

Pinna F, Breuhahn K. Pinna F, et al. Hepat Oncol. 2015 Jan;2(1):9-11. doi: 10.2217/hep.14.29. Epub 2015 Jan 12. Hepat Oncol. 2015. PMID: 30190981 Free PMC article. No abstract available.

139

The evolving field of intrahepatic cholangiocarcinoma.

Grandhi MS, Page AJ, Pawlik TM. Grandhi MS, et al. Hepat Oncol. 2015 Jan;2(1):5-8. doi: 10.2217/hep.14.30. Epub 2015 Jan 12. Hepat Oncol. 2015. PMID: 30190980 Free PMC article. No abstract available.

140

Hepatocellular carcinoma risk scores: ready to use in 2015?

Chen CJ, Lee MH, Liu J, Yang HI. Chen CJ, et al. Hepat Oncol. 2015 Jan;2(1):1-4. doi: 10.2217/hep.14.32. Epub 2015 Jan 12. Hepat Oncol. 2015. PMID: 30190979 Free PMC article. No abstract available.

141

The role of AEG-1 in the development of liver cancer.

Robertson CL, Srivastava J, Rajasekaran D, Gredler R, Akiel MA, Jariwala N, Siddiq A, Emdad L, Fisher PB, Sarkar D. Robertson CL, et al. Hepat Oncol. 2015;2(3):303-312. doi: 10.2217/hep.15.10. Hepat Oncol. 2015. PMID: 26798451 Free PMC article.

142

Molecular classification of hepatocellular carcinoma: potential therapeutic implications.

Goossens N, Sun X, Hoshida Y. Goossens N, et al. Hepat Oncol. 2015;2(4):371-379. doi: 10.2217/hep.15.26. Hepat Oncol. 2015. PMID: 26617981 Free PMC article.

143

Liver cancer oncogenomics: opportunities and dilemmas for clinical applications.

Marquardt JU, Andersen JB. Marquardt JU, et al. Hepat Oncol. 2015;2(1):79-93. doi: 10.2217/hep.14.24. Hepat Oncol. 2015. PMID: 26257864 Free PMC article.

144

Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decades.

Ulahannan SV, Rahma OE, Duffy AG, Makarova-Rusher OV, Kurtoglu M, Liewehr DJ, Steinberg SM, Greten TF. Ulahannan SV, et al. Hepat Oncol. 2015 Jan 1;2(1):39-50. doi: 10.2217/hep.14.36. Hepat Oncol. 2015. PMID: 25685318 Free PMC article.

145

Corrigendum.

[No authors listed] [No authors listed] Hepat Oncol. 2014 Oct;1(4):448. doi: 10.2217/hep.14.37. Epub 2014 Dec 11. Hepat Oncol. 2014. PMID: 30191904 Free PMC article.

146

Immunotherapy of hepatocellular carcinoma.

Sangro B, Palmer D, Melero I. Sangro B, et al. Hepat Oncol. 2014 Oct;1(4):433-446. doi: 10.2217/hep.14.16. Epub 2014 Dec 11. Hepat Oncol. 2014. PMID: 30190978 Free PMC article. Review.

147

Malignant transformation of hepatocellular adenoma.

Sempoux C, Balabaud C, Bioulac-Sage P. Sempoux C, et al. Hepat Oncol. 2014 Oct;1(4):421-431. doi: 10.2217/hep.14.14. Epub 2014 Dec 11. Hepat Oncol. 2014. PMID: 30190977 Free PMC article. Review.

148

Liver transplantation for metastatic neuroendocrine tumors.

Barbier L, Neuzillet C, Dokmak S, Sauvanet A, Ruszniewski P, Belghiti J. Barbier L, et al. Hepat Oncol. 2014 Oct;1(4):409-421. doi: 10.2217/hep.14.21. Epub 2014 Dec 11. Hepat Oncol. 2014. PMID: 30190976 Free PMC article. Review.

149

Predicting recurrence following radiofrequency percutaneous ablation for hepatocellular carcinoma.

Ganne-Carrié N, Nault JC, Ziol M, N'Kontchou G, Nahon P, Grando V, Bourcier V, Barge S, Beaugrand M, Trinchet JC, Seror O. Ganne-Carrié N, et al. Hepat Oncol. 2014 Oct;1(4):395-408. doi: 10.2217/hep.14.22. Epub 2014 Dec 11. Hepat Oncol. 2014. PMID: 30190975 Free PMC article. Review.

150

Radioembolization with yttrium-90 glass microspheres for patients with hepatocellular carcinoma: a review.

Schlaak JF. Schlaak JF. Hepat Oncol. 2014 Oct;1(4):387-393. doi: 10.2217/hep.14.20. Epub 2014 Dec 11. Hepat Oncol. 2014. PMID: 30190974 Free PMC article. Review.

151

CA 19-9 in combination with abdominal CT scan for the diagnosis of mass-forming intrahepatic cholangiocarcinoma.

Raunroadroong N, Sriplung H, Lertprasertsuke N, Pojchamarnwiputh S, Chiangmai WN, Sinsuwan W, Thongprasert S. Raunroadroong N, et al. Hepat Oncol. 2014 Oct;1(4):377-386. doi: 10.2217/hep.14.19. Epub 2014 Dec 11. Hepat Oncol. 2014. PMID: 30190973 Free PMC article.

152

Addition of bevacizumab to preoperative chemotherapy for colorectal liver metastases does not increase perioperative morbidity and mortality.

Giakoustidis A, Neofytou K, Khan A, Mudan S. Giakoustidis A, et al. Hepat Oncol. 2014 Oct;1(4):363-375. doi: 10.2217/hep.14.17. Epub 2014 Dec 11. Hepat Oncol. 2014. PMID: 30190972 Free PMC article.

153

Our experts highlight the most important research articles across the spectrum of topics relevant to the field of hepatic oncology.

Bressan AK, Ball CG, Dixon E. Bressan AK, et al. Hepat Oncol. 2014 Oct;1(4):361-362. doi: 10.2217/hep.14.27. Epub 2014 Dec 11. Hepat Oncol. 2014. PMID: 30190971 Free PMC article. No abstract available.

154

Our experts highlight the most important research articles across the spectrum of topics relevant to the field of hepatic oncology.

Coyne GO, Greten TF. Coyne GO, et al. Hepat Oncol. 2014 Oct;1(4):359-360. doi: 10.2217/hep.14.28. Epub 2014 Dec 11. Hepat Oncol. 2014. PMID: 30190970 Free PMC article. No abstract available.

155

Systemic therapy for hepatocellular carcinoma: why do we keep failing?

Kim BH, Park JW. Kim BH, et al. Hepat Oncol. 2014 Oct;1(4):355-358. doi: 10.2217/hep.14.23. Epub 2014 Dec 11. Hepat Oncol. 2014. PMID: 30190969 Free PMC article. No abstract available.

156

The biological and clinical challenge of liver cancer heterogeneity.

Wang XW, Thorgeirsson SS. Wang XW, et al. Hepat Oncol. 2014 Oct;1(4):349-353. doi: 10.2217/hep.14.18. Epub 2014 Dec 11. Hepat Oncol. 2014. PMID: 30190968 Free PMC article. No abstract available.

157

Current evidence and controversies in the incorporation of biologics for metastatic colorectal cancer.

Ciombor KK, Goldberg RM. Ciombor KK, et al. Hepat Oncol. 2014 Jun;1(3):331-345. doi: 10.2217/hep.14.13. Epub 2014 Sep 9. Hepat Oncol. 2014. PMID: 30190967 Free PMC article. Review.

158

miRNAs: new tools for molecular classification, diagnosis and prognosis of hepatocellular carcinoma.

Liu AM, Wang W, Luk JM. Liu AM, et al. Hepat Oncol. 2014 Jun;1(3):323-329. doi: 10.2217/hep.14.9. Epub 2014 Sep 9. Hepat Oncol. 2014. PMID: 30190966 Free PMC article. Review.

159

Liver transplantation for hepatocellular carcinoma: how far have we come and what is the future?

Chung H, Chapman WC. Chung H, et al. Hepat Oncol. 2014 Jun;1(3):309-321. doi: 10.2217/hep.14.8. Epub 2014 Sep 9. Hepat Oncol. 2014. PMID: 30190965 Free PMC article. Review.

160

Mechanisms of hepatocarcinogenesis in chronic hepatitis C.

Mitchell JK, McGivern DR. Mitchell JK, et al. Hepat Oncol. 2014 Jun;1(3):293-307. doi: 10.2217/hep.14.7. Epub 2014 Sep 9. Hepat Oncol. 2014. PMID: 30190964 Free PMC article. Review.

161

Rationale of transcatheter intra-arterial therapies of hepatic cancers.

Hickey RM, Lewandowski RJ, Salem R. Hickey RM, et al. Hepat Oncol. 2014 Jun;1(3):285-291. doi: 10.2217/hep.14.11. Epub 2014 Sep 9. Hepat Oncol. 2014. PMID: 30190963 Free PMC article. Review.

162

SIR-Spheres yttrium-90 radioembolization for the treatment of unresectable liver cancers.

Golfieri R. Golfieri R. Hepat Oncol. 2014 Jun;1(3):265-283. doi: 10.2217/hep.14.6. Epub 2014 Sep 9. Hepat Oncol. 2014. PMID: 30190962 Free PMC article. Review.

163

Management of hepatocellular carcinoma: time to be resilient.

Dufour JF. Dufour JF. Hepat Oncol. 2014 Jun;1(3):261-263. doi: 10.2217/hep.14.12. Epub 2014 Sep 9. Hepat Oncol. 2014. PMID: 30190961 Free PMC article. No abstract available.

164

Preventing hepatocellular carcinoma: the crucial role of chronic hepatitis B monitoring and antiviral treatment.

Toy M, Demirci U, So S. Toy M, et al. Hepat Oncol. 2014 Jun;1(3):255-257. doi: 10.2217/hep.14.10. Epub 2014 Sep 9. Hepat Oncol. 2014. PMID: 30190959 Free PMC article. No abstract available.

165

Alterations in the expression and activity of pre-mRNA splicing factors in hepatocarcinogenesis.

Berasain C, Elizalde M, Urtasun R, Castillo J, García-Irigoyen O, Uriarte I, Latasa MU, Prieto J, Avila MA. Berasain C, et al. Hepat Oncol. 2014 Apr;1(2):241-252. doi: 10.2217/hep.13.17. Epub 2014 Mar 20. Hepat Oncol. 2014. PMID: 30190958 Free PMC article. Review.

166

Endoscopic treatment options for cholangiocarcinoma.

Hou LA, Van Dam J. Hou LA, et al. Hepat Oncol. 2014 Apr;1(2):229-240. doi: 10.2217/hep.13.16. Epub 2014 Mar 20. Hepat Oncol. 2014. PMID: 30190957 Free PMC article. Review.

167

Current role of transarterial chemoembolization and radioembolization in the treatment of metastatic colorectal cancer.

Bester L, Meteling B, Boshell D, Saxena A, Morris DL. Bester L, et al. Hepat Oncol. 2014 Apr;1(2):215-228. doi: 10.2217/hep.13.21. Epub 2014 Mar 20. Hepat Oncol. 2014. PMID: 30190956 Free PMC article. Review.

168

Chemoembolization with DC Bead™ for the treatment of hepatocellular carcinoma: an update.

Malagari K, Emmanouil E, Pomoni M, Kelekis D. Malagari K, et al. Hepat Oncol. 2014 Apr;1(2):205-214. doi: 10.2217/hep.13.18. Epub 2014 Mar 20. Hepat Oncol. 2014. PMID: 30190955 Free PMC article. Review.

169

Sorafenib for the treatment of hepatocellular carcinoma.

Wörns MA, Galle PR. Wörns MA, et al. Hepat Oncol. 2014 Apr;1(2):189-204. doi: 10.2217/hep.13.20. Epub 2014 Mar 20. Hepat Oncol. 2014. PMID: 30190954 Free PMC article. Review.

170

Tivantinib in MET-high hepatocellular carcinoma patients and the ongoing Phase III clinical trial.

Rimassa L, Porta C, Borbath I, Daniele B, Finn RS, Raoul JL, Schwartz LH, He AR, Trojan J, Peck-Radosavljevic M, Abbadessa G, Goldberg T, Santoro A, Bruix J. Rimassa L, et al. Hepat Oncol. 2014 Apr;1(2):181-188. doi: 10.2217/hep.14.3. Epub 2014 Jan 29. Hepat Oncol. 2014. PMID: 30190953 Free PMC article. Review.

171

Ask the Experts: Management of hepatic metastases from neuroendocrine cancer.

Nagorney DM. Nagorney DM. Hepat Oncol. 2014 Apr;1(2):177-180. doi: 10.2217/hep.14.4. Epub 2014 Mar 20. Hepat Oncol. 2014. PMID: 30190952 Free PMC article.

172

Journal Watch: Our expert highlights the most important research articles across the spectrum of topics relevant to the field of hepatic oncology.

[No authors listed] [No authors listed] Hepat Oncol. 2014 Apr;1(2):173-175. doi: 10.2217/hep.14.1. Epub 2014 Mar 20. Hepat Oncol. 2014. PMID: 30190951 Free PMC article. No abstract available.

173

Who should undergo liver transplantation for hepatocellular carcinoma? Ablate, wait … and see!

Naugler WE, Schlansky B, Orloff SL. Naugler WE, et al. Hepat Oncol. 2014 Apr;1(2):165-168. doi: 10.2217/hep.14.2. Epub 2014 Mar 20. Hepat Oncol. 2014. PMID: 30190949 Free PMC article. No abstract available.

174

Limitations of screening for hepatocellular carcinoma.

Sherman M. Sherman M. Hepat Oncol. 2014 Apr;1(2):161-163. doi: 10.2217/hep.13.22. Epub 2014 Mar 20. Hepat Oncol. 2014. PMID: 30190948 Free PMC article. No abstract available.

175

Current state of nonsurgical therapies for cholangiocarcinoma.

Brass V, Kuhlmann JB, Blum HE. Brass V, et al. Hepat Oncol. 2014 Jan;1(1):135-142. doi: 10.2217/hep.13.9. Epub 2013 Dec 20. Hepat Oncol. 2014. PMID: 30190947 Free PMC article. Review.

176

Surgical management of colorectal liver metastases: a European perspective.

Dunne DF, Jones RP, Malik HZ, Fenwick SW, Poston GJ. Dunne DF, et al. Hepat Oncol. 2014 Jan;1(1):121-133. doi: 10.2217/hep.13.3. Epub 2013 Dec 20. Hepat Oncol. 2014. PMID: 30190946 Free PMC article. Review.

177

STAT3 in hepatocellular carcinoma: new perspectives.

Svinka J, Mikulits W, Eferl R. Svinka J, et al. Hepat Oncol. 2014 Jan;1(1):107-120. doi: 10.2217/hep.13.7. Epub 2013 Dec 20. Hepat Oncol. 2014. PMID: 30190945 Free PMC article. Review.

178

Insight into hepatocellular carcinoma biology with gadoxetate disodium-enhanced MRI.

Kagen A, Fowler K, Sirlin CB. Kagen A, et al. Hepat Oncol. 2014 Jan;1(1):95-105. doi: 10.2217/hep.13.11. Epub 2013 Dec 20. Hepat Oncol. 2014. PMID: 30190944 Free PMC article. Review.

179

Rationale for ablation of oligometastatic disease and the role of stereotactic body radiation therapy for hepatic metastases.

Rusthoven CG, Schefter TE. Rusthoven CG, et al. Hepat Oncol. 2014 Jan;1(1):81-94. doi: 10.2217/hep.13.12. Epub 2013 Dec 20. Hepat Oncol. 2014. PMID: 30190943 Free PMC article. Review.

180

Ablation therapy for hepatocellular carcinoma: past, present and future perspectives.

Niemeyer DJ, Simo KA, Iannitti DA, McKillop IH. Niemeyer DJ, et al. Hepat Oncol. 2014 Jan;1(1):67-79. doi: 10.2217/hep.13.8. Epub 2013 Dec 20. Hepat Oncol. 2014. PMID: 30190942 Free PMC article. Review.

181

Evolving role of vascular resection and reconstruction in hepatic surgery for malignancy.

Mekeel KL, Hemming AW. Mekeel KL, et al. Hepat Oncol. 2014 Jan;1(1):53-65. doi: 10.2217/hep.13.5. Epub 2013 Dec 20. Hepat Oncol. 2014. PMID: 30190941 Free PMC article. Review.

182

Assessing resectability in cholangiocarcinoma.

Sano T, Shimizu Y, Senda Y, Kinoshita T, Nimura Y. Sano T, et al. Hepat Oncol. 2014 Jan;1(1):39-51. doi: 10.2217/hep.13.6. Epub 2013 Dec 20. Hepat Oncol. 2014. PMID: 30190940 Free PMC article. Review.

183

Systemic therapy for hepatocellular carcinoma.

McNamara MG, Knox JJ. McNamara MG, et al. Hepat Oncol. 2014 Jan;1(1):23-38. doi: 10.2217/hep.13.10. Epub 2013 Dec 20. Hepat Oncol. 2014. PMID: 30190939 Free PMC article. Review.

184

Interview: Challenges and prospects for liver cancer management: treatment, prevention and collaboration.

Khan SA. Khan SA. Hepat Oncol. 2014 Jan;1(1):17-21. doi: 10.2217/hep.13.13. Epub 2013 Dec 20. Hepat Oncol. 2014. PMID: 30190938 Free PMC article.

185

Journal Watch: Our expert highlights the most important research articles across the spectrum of topics relevant to the field of hepatic oncology.

Sanchez W. Sanchez W. Hepat Oncol. 2014 Jan;1(1):15-16. doi: 10.2217/hep.13.19. Epub 2013 Dec 20. Hepat Oncol. 2014. PMID: 30190937 Free PMC article. No abstract available.

186

What do we know about the etiology of hepatoblastoma?

M Turcotte L, G Spector L. M Turcotte L, et al. Hepat Oncol. 2014 Jan;1(1):7-10. doi: 10.2217/hep.13.2. Epub 2013 Dec 20. Hepat Oncol. 2014. PMID: 30190935 Free PMC article. No abstract available.

187

Impact of a shortened surveillance interval on hepatocellular carcinoma survival.

Kim DY, Han KH. Kim DY, et al. Hepat Oncol. 2014 Jan;1(1):3-5. doi: 10.2217/hep.13.1. Epub 2013 Dec 20. Hepat Oncol. 2014. PMID: 30190934 Free PMC article. No abstract available.

188

Hepatic Oncology: a journal for all stakeholders in liver cancer management.

Finn RS, Bruix J. Finn RS, et al. Hepat Oncol. 2014 Jan;1(1):1. doi: 10.2217/hep.13.15. Epub 2013 Dec 20. Hepat Oncol. 2014. PMID: 30190933 Free PMC article. No abstract available.

189

A perspective on molecular therapy in cholangiocarcinoma: present status and future directions.

Andersen JB, Thorgeirsson SS. Andersen JB, et al. Hepat Oncol. 2014 Jan 1;1(1):143-157. doi: 10.2217/hep.13.4. Hepat Oncol. 2014. PMID: 24772266 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

189 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

189 results

Results by year